5 Results for "

IkBα

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "IkBα" in MCE Product Catalog:

Cat. No.: HY-13717
CAS No.: 220619-73-8
Purity:  99.94%
Synonyms: IRX4204; NRX194204; VTP 194204
Target:  

RAR/RXR Apoptosis

Research Areas:  

Inflammation/Immunology Cancer

AGN194204 (IRX4204) is an orally active and selective RXR agonist with Kd values 0.4 nM, 3.6 nM and 3.8 nM and EC50s of 0.2 nM, 0.8 nM and 0.08 nM for RXRα, RXRβ and RXRγ, respectively. AGN194204 is inactive against RAR. AGN194204 has anti-inflammatory and anticarcinogenic actions .
loading...
    loading...
Cat. No.: HY-153188
CAS No.: 2597343-08-1
Purity:  99.80%
Target:  

PROTACs Apoptosis IRAK

Research Areas:  

Cancer

JNJ-1013 is a potent and selective IRAK1 PROTAC degrader with an IC50s of 72, 443, 1071 nM for IRAK1, IRAK4, VHL FP respectively. JNJ-1013 induces apoptosis and increases the expression of cleavaged PARP. JNJ-1013 decreases the expression IRAK1, p-IKBα, pSTAT3(Tyr705) (Pink: ligand for target protein (HY-138834); black: linker (HY-Y1760); Blue: E3 ligase ligand (HY-112078)) .
loading...
    loading...
Cat. No.: HY-173210
CAS No.: 2251689-60-6
Target:  

Apoptosis TNF Receptor

Research Areas:  

Cancer

TNF-α-IN-22 (Compound 30) is a TNFα inhibitor. It can induce Apoptosis by inhibiting the downregulation of IkBα induced by TNFα and blocking the cell cycle. TNF-α-IN-22 can be used in the research of triple-negative breast cancer .
loading...
    loading...
Cat. No.: HY-147906
CAS No.: 2453228-45-8
Target:  

Apoptosis PARP

Research Areas:  

Cancer

Anticancer agent 71 (Compound 4b) is a potent anticancer agent and induces apoptosis. Anticancer agent 71 arrests cell cycle at G2/M phase and induces apoptosis through upregulating Bax, Ikb-α and cleaved PARP and downregulating Bcl-2 expression levels. Anticancer agent 71 shows antiproliferative activity .
loading...
    loading...
Cat. No.: HY-183448
CAS No.: 117666-86-1
ETMTC is an orally active anti-inflammatory and antioxidant agent. ETMTC inhibits IKK-mediated phosphorylation and degradation of IkBα, blocks nuclear translocation and activation of NF-κB, and reduces the expression of ICAM-1, VCAM-1, E-selectin, Th2 cytokines and eosinophil chemokines. ETMTC abrogates neutrophil adhesion to endothelial monolayers and inhibits TNF-α-induced ROS production. ETMTC activates Nrf2, and enhances the activities of mitochondrial complex I and IV. ETMTC reduces lipid peroxidation levels, oxidative DNA damage, cytochrome c and caspase 9 activity, and decreases goblet cell metaplasia and subepithelial fibrosis. ETMTC can be used for the research of inflammatory diseases and asthma .
loading...
    loading...